Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis

Autor: AKARıRMAK, Ü, KOÇYIĞIT, H, ESKIYURT, N, ESMAEILZADEH, S, KURU, Ö, YALÇINKAYA, EY, PEKER, Ö, EKIM, AA, ÖZGIRGIN, N, ÇALıŞ, M, Rezvani, AYLİN, ÇEVIKOL, A, EYIGÖR, S, ŞENDUR, ÖF, İRDESEL, J, INSTRUCT, Study

Publikováno v: Acta Orthopaedica et Traumatologica Turcica, Vol 50, Iss 4, Pp 415-423 (2016)
Acta Orthopaedica et Traumatologica Turcica
Scipedia Open Access
Scipedia SL

WOS: 000384750400006
PubMed ID: 27524671
Objective: In our study, we aimed to evaluate the influence of training on compliance and persistence with bisphosphonate treatment given on a weekly vs. monthly basis in postmenopausal osteoporosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2224e5d4ce4c1a51067594588ba8e9d1
https://www.scipedia.com/public/Akarirmak_et_al_2016a

Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis

Autor: Akarirmak Ü., Koçyiğit H., Eskiyurt N., Esmaeilzadeh S., Kuru O., Yalçinkaya E.Y., Peker O.

Objective: In our study, we aimed to evaluate the influence of training on compliance and persistence with bisphosphonate treatment given on a weekly vs. monthly basis in postmenopausal osteoporosis patients. Methods: A total of 979 patients with pos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10652::ce888235bb4d1d88df10e780ed80b057
https://hdl.handle.net/11499/47672

Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis

Autor: Akarirmak, Ü., Koçyiğit, H., Eskiyurt, N., Esmaeilzadeh, S., Kuru, O., Yalçinkaya, E.Y., Peker, O., Ekim, A.A., Özgirgin, N., çalis, M., Rezvani, A., çevikol, A., Eyigör, S., Şendur, O.F., Irdesel, J., Karaagac, F., Baybali, A., Erdogan, N., Bodur, H., Kuran, B., Ozdemir, F., Gunaydin, R., Sertpoyraz, F.M., Jarar, C., Topuz, O., Borman, P., Erdem, R., Turhanoglu, A., Bahadir, C., Gengor, F., Akgol, E., Ozel, S., Orzan, C., Akyuz, M., Cevik, R., Ucan, H.

Objective: In our study, we aimed to evaluate the influence of training on compliance and persistence with bisphosphonate treatment given on a weekly vs. monthly basis in postmenopausal osteoporosis patients. Methods: A total of 979 patients with pos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3566::7f89754583c07f4b228b739a42fa39ab
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/9953

Günlük veya haftalık alendronat veya risendronat alan postmenopozal osteoporozlu kadınlarda aylık ibandronat için hasta tercihinin değerlendirildiği açık- etiketli, prospektif, çok-merkezi, iki-aşamalı çalışma-BONCURE: Türkiye alt-çalışması

Autor: Eskiyurt, N, Irdesel, J, Sepici, V, Uǧurlu, H, Kirazli, Y, Ardiç, F, Bütün, B, Akyüz, G, Cerrahoǧlu, L, Şendur, Ö.F, Yalçin, P, Öncel, S, Saridoǧan, M, Sarpel, T, Tosun, M, Kutsal, Y.G, Şenel, K, Gürsoy, S, Cantürk, F, Demir, H, Özdener, F, Öncel, H.

Amaç: BONCURE (Mevcut Bisfosfonat Kullanıcıları İçin Bonviva Bölgesel Avrupa Çalışması) ile daha önce günlük veya haftalık alendronat veya risendronat alan postmenopozal osteoporozu olan kadınlarda aylık ibandronat için hasta tercih

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f9cca4162fcde9d5eb58532b2b528b03
https://hdl.handle.net/11454/19009

Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study

Autor: Eskiyurt, N., Irdesel, J., Sepici, V., Ugurlu, H., Kirazli, Y., Ardıç, Füsun, Bütün, B.

Aim: BONCURE (Bonviva for Current Bisphosphonate Users Regional European Trial), aimed to evaluate patient preference with monthly ibandronate in women with postmenopausal osteoporosis who previously received daily or weekly alendronate or risendrona

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0f20d9cd63dc9f53fea6e95edda2b1f5
https://hdl.handle.net/20.500.12395/28800